We use cookies to improve your experience on this site. By viewing our pages, you give us consent to use cookies. Find out more.

Don’t invest unless you’re prepared to lose all the money you invest. NextFin promotes high - risk investments and you are unlikely to be protected if something goes wrong.
Take 2 minutes to learn more.

Equity Crowdfunding Pitches

Showing results
Inspira Pharmaceuticals (IP) is forming a possible new therapy for COVID-19. IP asserts that its in-lab plant-based molecular formulation has killed over 95% of the SARS-CoV-2 virus. The company aims to understand whether a COVID-19 patient can safely inhale the formulation directly into their lungs as an effective treatment. IP has secured cornerstone investment from biotech angel investors and a Singaporean Venture Capitalist (VC) for its formula. IP argues that its technology has the potential for addressing other respiratory infections such as cystic fibrosis, influenza and the common cold in the coming months. The company will use the investment to develop an effective new drug, which will include further laboratory analysis, safety testing, and preparation for human trials.
days to go: Expired investment: £357,179
Please watch the video for more information
days to go: Expired investment: £1,210,000
Please watch the video for more information
days to go: Expired investment: £360,250
Please watch the video for more information
days to go: Expired investment: £257,501
Jupiter Diagnostics provide a patent-protected portable reader and test card to provide reliable and cost-effective blood results. Each test card has the ability to measure multiple tests from a prick of blood from the finger and can deliver laboratory-quality results in just ten minutes.
days to go: Expired investment: £2,005,050
Licklist is currently one of the UK's largest directories for nightlife and music festivals. Using Licklist, 18-30 year olds can plan their perfect night out, allowing them to discover events, offers and venues. For nightclubs and bars, Licklist provide them with tools that help them get more people into their venue.
days to go: Expired investment: £103,288
Live&Loud is an ultimate entertainment booking service for venues and artists. It acts as a digital broker ensuring artists and venues get all the benefits of live music, hassle free. From event planning to booking live gigs to promotion, Live&Loud provides all the tools and help to its clients, saving them time and money. Till date, the company has worked with more than 13,000 artists, arranged over 5,000 events and has built strong ties with some of the UK’s leading hospitality brands. Backed by the former CEO of Sony Music & EMI and run by an industry experienced team, Live&Loud is constantly working towards capitalising the UK live music market.
days to go: Expired investment: £517,310
A medical condition management platform allowing clinicians to create their own app to improve a patient's health whilst reducing costs. Living With develops smart apps specific to a person's condition, they currently have 3 products with another in the development stage. Their primary app, Squeezy, is the top paid medical app in the UK that helps patients with their pelvic floor exercises. Other apps, allow clinicians to monitor a patient's bowel and bladder health, as well as those with rheumatoid arthritis. These apps are already in use at multiple NHS Trusts and clinics. Funds are being raised to complete development of their apps to help those with lupus and lung cancer, in addition to further developing their existing products. The company aims to have thousands of apps that will be available worldwide to provide self-service treatment at any time. Living With is expecting to earn £1.07m in revenue by the end of March 2019.
days to go: Expired investment: £250,000
Like a lot of young independent British film companies, 721 Productions had only a modest budget with which to enter the $36 billion global film industry in 2014 (an industry that seems recession proof given that global box office revenues have seen a 22% increase since 2009).  Despite the low budget, director Paul Emmanuel still produced a piece of brilliance with ‘The Maid’ - a romantic drama that hit the silver screen in early 2014 and subsequently went on to pick up various film accolades, including multiple awards, a nomination for Best UK Feature Film and screenings at the prestigious London and New York film festivals. Since the overwhelming response to what was 721 Productions' very first film, the team has been hard at work on its latest film ‘Secrets of the Lost Souls’.  Paul Emmanuel is once again steering the ship second time around – albeit with a greater depth of industry connections and knowhow compared to the first. He is working alongside other talented and versatile filmmakers David C. G. Hare – who himself has built an impressive career over the past 15 years – and the award-winning cinematographer Steven Marshall who has over 9 years experience in his field and has worked on movies screened at film festivals in Cannes, Venice and Berlin.  The latest film production will cost £80,000 – you'd be forgiven for thinking that that's a small amount for the production of a movie. But with advanced digital cinema technology available to modern-day filmmakers at reasonable prices, costs can be contained. The film ‘Paranormal Activity’ for example, cost $15,000 to make and grossed over $107,000,000 at the box office – testament not only to the relatively small investment these types of productions need, but also to why Horror/Action genres are widely recognised as offering the highest rates of return on investment in the movie industry. Like Paranormal Activity ‘Secrets of the Lost Souls’ is a supernatural horror thriller aimed at the more lucrative US market.  Production is scheduled to begin early next year and 721 Productions wants to make investors become part of the journey – one featuring ongoing film updates, special mentions, exclusive screenings, site visits, film previews and a wrap party. How far you travel on that journey with the production team depends on how much you invest. Investors pledging money to this pitch will receive exciting investor rewards and shares in a movie from what is an emerging British film production company. Check out the 'rewards' section for more details.
days to go: Expired investment: £24,700
Luxia targeted travel media connects global advertisers with travellers across 4 and 5 star hotels across the world using targeted media. This ground breaking technology is currently being used in 1.5 millions rooms! 
days to go: Expired investment: £395,500
  • Internet Business Awards Category Award Winner 2015
  • Hertfordshire Business Awards Finalist 2014

As seen in:

  • The Guardian
  • Financial Times
  • Yahoo! Finance
  • The Times
  • The Daily Telegraph